Luciana Hagstrom Hagström

Dr. Luciana Hagstrom Hagström

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in International Journal for Parasitology: Drugs and Drug Resistance
Verified
Journal Article
Open access
VRVanessa Ribeiro
Vanessa Ribeiro
NDNayra Suélen Gomes Dias
Nayra Suélen Gomes Dias
TPTaís Paiva
Taís Paiva
LHLuciana Hagstrom Hagström
Luciana Hagstrom Hagström
NNNadjar Nitz Nitz
Nadjar Nitz Nitz
MHMariana Hecht
Mariana Hecht
Chagas disease (CD) is a tropical neglected illness, affecting mainly populations of low socioeconomic status in Latin America. An estimated 6 to 8 million people worldwide are infected with Trypanosoma cruzi, the etiological agent of CD. Despite being one of the main global health problems, this disease continues without effective treatment during the chronic phase of the infection. The limitation of therapeutic strategies has been one of the biggest challenges on the fight against CD. Nifurtimox and benznidazole, developed in the 1970s, are still the only commercial options with established efficacy on CD. However, the efficacy of these drugs have a proven efficacy only during early infection and the benefits in the chronic phase are questionable. Consequently, there is a growing need for new pharmacological alternatives, either by optimization of existing drugs or by the formulation of new compounds. In the present study, a literature review of the currently adopted therapy, its concomitant combination with other drugs, and potential future treatments for CD was performed, considering articles published from 2012. The revised articles were selected according to the protocol of treatment: evaluation of drug association, drug repositioning and research of new drugs. As a result of the present revision, it was possible to conclude that the use of benznidazole in combination with other compounds showed better results when compared with its use as a single therapy. The search of new drugs has been the strategy most used in pursuing more effective forms of treatment for CD. However, studies have still focused on basic research, that is, they are still in a pre-clinical stage, using methodologies based on in vitro or in animal studies.

27 December 2009 in Cell Proliferation
Verified
Journal Article
Open access
PDF file
TLT. Launay
T. Launay
LHLuciana Hagstrom Hagström
Luciana Hagstrom Hagström
SLS. Lottin‐Divoux
S. Lottin‐Divoux
DMD. Marchant
D. Marchant
PQP. Quidu
P. Quidu
MBM. Beaudry
M. Beaudry
Objectives: The aim of this study was to evaluate whether hypoxia and/or erythropoietin would be able to modulate proliferation/differentiation processes of rat and human myoblasts. Materials and methods: Rat L6 and primary human myoblasts were grown in 21% or 1% O2 in the presence or absence of recombinant human erythropoietin (RhEpo). Presence of erythropoietin receptors (EpoR) was assayed using RT‐PCR and Western blotting techniques. Cell proliferation was evaluated by determining the doubling time and kinetics of cultures by counting cells. Cell differentiation was analysed by determining myogenic fusion index using antibodies against the myosin heavy chain. Expression of myogenin and myosin heavy chain (MHC) proteins were evaluated using the Western blotting technique. Results: After 96 h culture in growth medium for 2.5 and 9 h, doubling time of L6 and human primary myoblasts respectively, had increased in 1% O2 conditions (P < 0.01). Kinetics of culture showed alteration in proliferation at 72 h in L6 myoblast cultures and at 4 days in human primary myoblasts. The myogenic fusion index had reduced by 30% in L6 myoblasts and by 20% in human myoblasts (P < 0.01). Expression of myogenin and MHC had reduced by around 50%. Despite presence of EpoR mRNA and protein, RhEpo did not counteract the effects of hypoxia either in L6 cells or in human myoblasts. Conclusions: The data show that exposure to hypoxic conditions (1% O2) of rat and human myoblasts altered their proliferation and differentiation processes. They also show that Epo is not an efficient growth factor to counteract this deleterious effect.

1 February 2021 in Acta Tropica
Verified
Journal Article
Closed access
ITIsabella Márcia Soares Nogueira Teotônio
Isabella Márcia Soares Nogueira Teotônio
JCJuliana Lott de Carvalho
Juliana Lott de Carvalho
Luiz Claudio CastroLuiz Claudio Castro
Luiz Claudio Castro
NNNadjar Nitz
Nadjar Nitz
LHLuciana Hagstrom Hagström
Luciana Hagstrom Hagström
MHMariana Hecht
Mariana Hecht

9 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TMThaís Tâmara Castro Minuzzi-Souza
Thaís Tâmara Castro Minuzzi-Souza
NNNadjar Nitz
Nadjar Nitz
CCCésar Augusto Cuba Cuba
César Augusto Cuba Cuba
LHLuciana Hagstrom Hagström
Luciana Hagstrom Hagström
MHMariana Machado Hecht
Mariana Machado Hecht
RGRodrigo Gurgel-Gonçalves
Rodrigo Gurgel-Gonçalves
Vector-borne pathogens threaten human health worldwide. Despite their critical role in disease prevention, routine surveillance systems often rely on low-complexity pathogen detection tests of uncertain accuracy. In Chagas disease surveillance, optical microscopy (OM) is routinely used for detecting Trypanosoma cruzi in its vectors. Here, we use replicate T. cruzi detection data and hierarchical site-occupancy models to assess the reliability of OM-based T. cruzi surveillance while explicitly accounting for false-negative and false-positive results. We investigated 841 triatomines with OM slides (1194 fresh, 1192 Giemsa-stained) plus conventional (cPCR, 841 assays) and quantitative PCR (qPCR, 1682 assays). Detections were considered unambiguous only when parasitologists unmistakably identified T. cruzi in Giemsa-stained slides. qPCR was >99% sensitive and specific, whereas cPCR was ~100% specific but only ~55% sensitive. In routine surveillance, examination of a single OM slide per vector missed ~50–75% of infections and wrongly scored as infected ~7% of the bugs. qPCR-based and model-based infection frequency estimates were nearly three times higher, on average, than OM-based indices. We conclude that the risk of vector-borne Chagas disease may be substantially higher than routine surveillance data suggest. The hierarchical modelling approach we illustrate can help enhance vector-borne disease surveillance systems when pathogen detection is imperfect.

1 June 2017 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
PAPerla F Araujo
Perla F Araujo
AAAdriana B Almeida
Adriana B Almeida
CPCarlos F Pimentel
Carlos F Pimentel
ASAdriano R Silva
Adriano R Silva
ASAlessandro Sousa
Alessandro Sousa
ATAntonio Rl Teixeira
Antonio Rl Teixeira
Key words: Amazon; Trypanosoma cruzi; Chagas disease; family study; humans; epidemiology

26 January 2016 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
TMThaís Tâmara Castro Minuzzi-Souza
Thaís Tâmara Castro Minuzzi-Souza
NNNadjar Nitz Nitz
Nadjar Nitz Nitz
MKMonique Britto Knox
Monique Britto Knox
FRFilipe Reis
Filipe Reis
LHLuciana Hagstrom Hagström
Luciana Hagstrom Hagström
RGRodrigo Gurgel-Gonçalves
Rodrigo Gurgel-Gonçalves
Neotropical primates are important sylvatic hosts of Trypanosoma cruzi, the etiological agent of Chagas disease. Infection is often subclinical, but severe disease has been described in both free-ranging and captive primates. Panstrongylus megistus, a major T. cruzi vector, was found infesting a small-primate unit at Brasília zoo (ZooB), Brazil. ZooB lies close to a gallery-forest patch where T. cruzi circulates naturally. Here, we combine parasitological and molecular methods to investigate a focus of T. cruzi infection involving triatomine bugs and Neotropical primates at a zoo located in the Brazilian Savannah. We assessed T. cruzi infection in vectors using optical microscopy (n = 34) and nested PCR (n = 50). We used quantitative PCR (qPCR) to examine blood samples from 26 primates and necropsy samples from two primates that died during the study. We determined parasite lineages in five vectors and two primates by comparing glucose-6-phosphate isomerase (G6pi) gene sequences. Trypanosoma cruzi was found in 44 vectors and 17 primates (six genera and eight species); one Mico chrysoleucus and one Saguinus niger had high parasitaemias. Trypanosoma cruzi DNA was detected in three primates born to qPCR-negative mothers at ZooB and in the two dead specimens. One Callithrix geoffroyi became qPCR-positive over a two-year follow-up. All G6pi sequences matched T. cruzi lineage TcI. Our findings strongly suggest vector-borne T. cruzi transmission within a small-primate unit at ZooB – with vectors, and perhaps also parasites, presumably coming from nearby gallery forest. Periodic checks for vectors and parasites would help eliminate T. cruzi transmission foci in captive-animal facilities. This should be of special importance for captive-breeding programs involving endangered mammals, and would reduce the risk of accidental T. cruzi transmission to keepers and veterinarians.